These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 24612200)

  • 1. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
    Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
    Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.
    Weir MA; Gomes T; Mamdani M; Juurlink DN; Hackam DG; Mahon JL; Jain AK; Garg AX
    Nephrol Dial Transplant; 2011 Jun; 26(6):1888-94. PubMed ID: 20974644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
    Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
    Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J; Brouwers MC; Stehouwer CD; Krings A; Leufkens HG; Driessen JH; de Vries F; Burden AM
    BMJ; 2016 Jul; 354():i3625. PubMed ID: 27413017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
    Kostev K; Dippel FW; Rathmann W
    Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes.
    Monami M; Dicembrini I; Kundisova L; Zannoni S; Nreu B; Mannucci E
    Diabetes Obes Metab; 2014 Sep; 16(9):833-40. PubMed ID: 24635837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
    Davis TME; Bruce DG; Finn J; Curtis BH; Barraclough H; Davis WA
    Diabetes Obes Metab; 2019 Mar; 21(3):648-657. PubMed ID: 30370611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic variations in the risk of hypoglycaemia among people with Type 2 diabetes prescribed insulins and/or sulfonylureas: a historical cohort study using general practice-recorded data.
    Malawana M; Hutchings A; Mathur R; Robson J
    Diabet Med; 2018 Dec; 35(12):1707-1715. PubMed ID: 30264528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas.
    Stahl M; Berger W
    Diabet Med; 1999 Jul; 16(7):586-90. PubMed ID: 10445835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
    Koro CE; Bowlin SJ; Weiss SR
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study.
    Zaccardi F; Ling S; Lawson C; Davies MJ; Khunti K
    Diabetologia; 2020 Oct; 63(10):2129-2139. PubMed ID: 32728893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemia in hospitalized patients treated with sulfonylureas.
    Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
    Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.
    Liatis S; Mylona M; Kalopita S; Papazafiropoulou A; Karamagkiolis S; Melidonis A; Xilomenos A; Ioannidis I; Kaltsas G; Lanaras L; Papas S; Basagiannis C; Kokkinos A
    Diabetes Metab; 2015 Apr; 41(2):126-31. PubMed ID: 25468446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and the risk of head and neck cancer: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC; Quilliam BJ
    Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.